Skip to main content
. 2020 May 16;18(5):261. doi: 10.3390/md18050261

Figure 9.

Figure 9

Schematic illustration of fucosterol-triggering anticancer mechanisms in human ovarian cancer cells, which occur via decreasing PCNA expression and cell-cycle regulatory protein expressions in ES2 and OV90 cells.